104617-50-7

Basic information

• Product Name: N-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide
• Synonyms: N-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide;[N-(2-Amino-4,5,6,7- tetra hydro benzo(d) thiazol-6-yl) acetamide hydro bromide;N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide monohydrobromide;N-(2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide hydrobromide;N-[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide hydrobromide
• CAS NO: 104617-50-7
• Molecular Formula: BrH*C₉H₁₃N₃OS
• Molecular Weight: 292.19596
• Mol File: 104617-50-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide(104617-50-7)
• EPA Substance Registry System: N-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide(104617-50-7)

Safety Data

• Hazardous Substances Data: 104617-50-7(Hazardous Substances Data)

Usage

Uses

N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide Hydrobromide is an analogue hydrobromide salt of (S)-N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide (A618835), an intermediate in the synthesis of Pramipexole (P700755), a dopamine-D2-receptor agonist and antiparkinsonian.

Upstream product

• 17356-08-0 thiourea 
• 687639-03-8 2-bromo-4-acetamidocyclohexanone 
• 27514-08-5 N-(4-oxocyclohexyl)acetamide 

Downstream Products

• 104632-26-0 pramipexole 
• 104632-25-9 pramipexole dihydrochloride 
• 106092-09-5 (S)-4,5,6,7-tetrahydrobenzo[d]thiazol-2,6-diamine 
• 106006-84-2 (S)?2?amino?6?propionamido?4,5,6,7?tetrahydrobenzothiazole 
• 106006-83-1 2,6-diamino-4,5,6,7-tetrahydro-benzthiazole 

Relevant articles and documents

IMPROVED PROCESS FOR THE PREPARATION OF (S)-2-AMINO-4,5,6,7-TETRAHYDRO-6 - (PROPYLAMINO) BENZOTHIAZOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

The present invention relates to an improved process for the preparation of of (S)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole and its pharmaceutically acceptable salts. Specifically relates to the compound represented by the following structural formula- Ia.

Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals

This invention relates to new tetrahydrobenzthiazoles of general formula STR1 wherein R1 represents a hydrogen atom, an alkyl group, an alkenyl or alkynylk group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the above mentioned phenyl nuclei may each be substituted by 1 or 2 halogen atoms, R2 represents a hydrogen atom or an alkyl group, R3 represents a hydrogen atom, an alkyl group a cycloalkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the phenyl nucleus may be substituted by flurorine, chlorine or bromine atoms, R4 represents a hydrogen atom, an alkyl group, an alkyl or alkenyl group, or R3 and R4 together with the nitrogen atom between them represent a pyrrolidino, piperidino, hexamethyleneimino or morpholino group, the enantiomers and the acid addition salts thereof. The compounds of general formula I above in which one of the groups R1 or R3 or both groups R1 and R3 represent an acyl group are valuable intermediate products for preparing the other compounds of general formula I which have valuable pharmacological properties. The new compounds may be prepared using methods known per se.